Read the Beforeitsnews.com story here. Advertise at Before It's News here.
Profile image
By Midas Letter (Reporter)
Contributor profile | More stories
Story Views
Now:
Last hour:
Last 24 hours:
Total:

Tepid Reaction in Canadian Weedstocks Following Big Canopy Growth Corp (TSE:WEED) Acquisition

% of readers think this story is Fact. Add your two cents.


Although Canopy Growth Corp (TSE:WEED) (NYSE:CGC) (FRA:11L1) delivered an unexpected surprise to the market yesterday, Canadian weedstocks have reacted with a collective yawn. This may be somewhat surprising to investors—many of whom were expecting this cross border M&A to send shock waves throughout the market. We explore further.

To recap, Canopy Growth administered an official press release this morning that confirmed yesterday evening’s hysteria. The company announced that they have entered into a definitive arrangement agreement that grants them the right to acquire 100% share ownership in Acreage Holdings Inc., at such time as cannabis production and sale becomes federally legal in the United States. All told, the transaction is valued at approximately US$3.4 billion on a fully-diluted basis—in both cash and stock—on a 0.5818 CGC – ACRG exchange ratio basis. 

Both companies will also execute a licensing agreement granting Acreage access to Canopy Growth’s brands such as Tweed and Tokyo Smoke, along with other intellectual property. Once the all rights are exercised, Acreage will become part of the world’s biggest and most expansive cannabis company. Until then, the two companies will continue to operate independently.

Given that M&A is traditionally one of surefire ways to spark animal spirits, why is the Canadian side of the market not responding? Perhaps the answer lies in timing.

As we’ve witnessed lately, Canadian weedstocks have been mostly weak outside of a few pockets of strength—cannabis oil stocks specifically. Remember, the weakness in HMMJ is occurring despite an historic melt-up rally in broad market indexes that are attaining new all-time high. This shouldn’t occur in a strong market.

Disappointing earning report follow-through in Cronos Group, Tilray, CannTrust Holdings and Aphria has put a damper on near-term earnings expectations. Despite Canopy Growth blazing M&A trails, leading to today’s strong response ($61.78, $4.67, ↑8.18%), somehow it seems all too far away. The market sports a decidedly “show-me” attitude right now.

As well, Canopy Growth’s announcement is completely contingent on U.S. lawmakers allowing cannabis production and sale becomes federally legal in the United States. Until that happens, the M&A taking place is only 1/2 complete. That doesn’t mitigate the importance of today’s announcement, but it does minimize its potential impact on price action in the marketplace right now. The importance of SAFE Banking Act/STATES Act (the first in progress; the second upcoming) legislation passing on Capitol Hill and signed into law have taken on a whole new meaning.

For its part, U.S, multi-state operators (MSOs) have fared much better today. The U.S. Marijuana Index is currently ↑2.56%—around 2.5x its Canadian benchmark counterpart (HMMJ)—although early euphoria has faded somewhat. Several leading MSOs touched high-single-digit and double-digit percentage gains, and have kept the majority of them. Ultimately, MSOs will be the biggest near-term beneficiaries of upcoming cross border M&A, even if much of the premium is tethered to Canadian acquirers stock prices. Once Canadian weedstocks prices turn around, both markets will benefit.

Midas Letter congratulates Canopy Growth for leading yet another forward-looking and market-changing initiative, at a time when collective market performance is rather skittish on the Canadian side. Just like in mid-August 2018, Canopy Growth has changed the narrative and given investors something to look forward to. We wouldn’t expect anything less from King Canopy.

Midas Letter will have additional coverage as events warrant.

Original article: Tepid Reaction in Canadian Weedstocks Following Big Canopy Growth Corp (TSE:WEED) Acquisition

©2019 Midas Letter. All Rights Reserved.


Source: https://midasletter.com/2019/04/tepid-reaction-in-canadian-weedstocks-following-big-canopy-growth-corp-tseweed-acquisition/


Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world.

Anyone can join.
Anyone can contribute.
Anyone can become informed about their world.

"United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.

Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world. Anyone can join. Anyone can contribute. Anyone can become informed about their world. "United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.


LION'S MANE PRODUCT


Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules


Mushrooms are having a moment. One fabulous fungus in particular, lion’s mane, may help improve memory, depression and anxiety symptoms. They are also an excellent source of nutrients that show promise as a therapy for dementia, and other neurodegenerative diseases. If you’re living with anxiety or depression, you may be curious about all the therapy options out there — including the natural ones.Our Lion’s Mane WHOLE MIND Nootropic Blend has been formulated to utilize the potency of Lion’s mane but also include the benefits of four other Highly Beneficial Mushrooms. Synergistically, they work together to Build your health through improving cognitive function and immunity regardless of your age. Our Nootropic not only improves your Cognitive Function and Activates your Immune System, but it benefits growth of Essential Gut Flora, further enhancing your Vitality.



Our Formula includes: Lion’s Mane Mushrooms which Increase Brain Power through nerve growth, lessen anxiety, reduce depression, and improve concentration. Its an excellent adaptogen, promotes sleep and improves immunity. Shiitake Mushrooms which Fight cancer cells and infectious disease, boost the immune system, promotes brain function, and serves as a source of B vitamins. Maitake Mushrooms which regulate blood sugar levels of diabetics, reduce hypertension and boosts the immune system. Reishi Mushrooms which Fight inflammation, liver disease, fatigue, tumor growth and cancer. They Improve skin disorders and soothes digestive problems, stomach ulcers and leaky gut syndrome. Chaga Mushrooms which have anti-aging effects, boost immune function, improve stamina and athletic performance, even act as a natural aphrodisiac, fighting diabetes and improving liver function. Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules Today. Be 100% Satisfied or Receive a Full Money Back Guarantee. Order Yours Today by Following This Link.


Report abuse

    Comments

    Your Comments
    Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

    MOST RECENT
    Load more ...

    SignUp

    Login

    Newsletter

    Email this story
    Email this story

    If you really want to ban this commenter, please write down the reason:

    If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.